Sponsors Often Compromise Ethics For Cost Efficiency With Trial Outsourcing
This article was originally published in PharmAsia News
Executive Summary
As drug sponsors opt to cut costs by outsourcing clinical trials to emerging nations such as India, incomplete patient consent forms are one of several rising ethical concerns linked to such demand